Highland Capital Management (Texas)’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $506K | Hold |
24,300
| – | – | 0.03% | 220 |
|
|
2019
Q1 | $543K | Hold |
24,300
| – | – | 0.03% | 208 |
|
|
2018
Q4 | $581K | Sell |
24,300
-269,860
| -92% | -$6.45M | 0.04% | 187 |
|
|
2018
Q3 | $8.03M | Buy |
294,160
+5,360
| +2% | +$146K | 0.44% | 56 |
|
|
2018
Q2 | $7.77M | Buy |
288,800
+45,500
| +19% | +$1.22M | 0.44% | 57 |
|
|
2018
Q1 | $7.74M | Buy |
243,300
+93,550
| +62% | +$2.98M | 0.4% | 62 |
|
|
2017
Q4 | $5.66M | Buy |
+149,750
| New | +$5.66M | 0.26% | 83 |
|